GASTRIC CANCER - UPDATE
DOI:
https://doi.org/10.20398/jscr.v14i2.34976Keywords:
Gastric câncer. risk factors. Biomarkers. Chemotherapy. Gastrectomy. Lymphadenectomy.Abstract
Objective: This review aims to provide an update on the recent advances in the diagnosis, biomarkers, chemotherapy and surgical treatment of gastric câncer (GC). Methods: For the preparation of this review, the authors used the PubMed, Embase and SciELO data-bases. The following keywords were used: gastric cancer, risk factors, epidemiology, biomarkers, chemotherapy, gastrectomy, lymphadenectomy, multimodal treatment. Conclusion: This review includes comments regarding classification, risk factors, epidemiology of gastric câncer, diagnostic, surgery and multimodal treatment. Besides the advances in the management of GC, currently, patients with early and advanced gastric cancer are still mainly treated by surgery, (D-2 gastrectomy) combined with chemotherapy and chemoradiotherapy, as well as targeting therapy to improve surgical treatment.
Key-words: Gastric câncer. risk factors. Biomarkers. Chemotherapy. Gastrectomy. Lymphadenectomy. Multimodal treatment.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 JOURNAL OF SURGICAL AND CLINICAL RESEARCH
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Uma vez aceito o artigo para publicação, os autores transferem os Direitos Autorais (copyright) para o J Surg Cl Res, responsabilizam-se pelo conteúdo do trabalho, confirmam sua originalidade e se comprometem a não publicá-lo em outros periódicos na íntegra ou em parte.